1. FDA moves to ease path for biosimilars as Trump seeks to cut drug costs  statnews.com
  2. US FDA proposes moves to speed availability of some cheaper biotech medicines  Reuters
  3. US set to speed up approval for some generic drugs in blow to Big Pharma  Financial Times
  4. FDA to speed up approvals of generic biologic medicines as Trump targets high drug costs  CNBC
  5. WATCH: Health Secretary RFK Jr. announces new FDA move to fast-track biosimilar drug approvals  PBS